In this episode, Rob and Greg discuss an interesting piece of 340B history – the Morford letter (25:31). Rob shares his understanding of the origins of the letter and contemporary application of the letter as it relates to the recent debate around the 340B-eligible patient definition.
But first, the guys catch up on 340B news, including:
-A reminder of 340B protections offered under the 2022 Consolidated Appropriations Act (i.e., DSH attestation)
-Legislative updates from the House E&C health subcommittee bill mark-up session
-Updated manufacturer restrictions for contract pharmacies
To access a copy of the Morford Letter: http://content.spendmend.com/assets/Morford-Letter-1.26.01.pdf
